Fierce competition among the middle-men in Japan’s pharmaceutical industry has created a healthy environment for private equity firms looking to consolidate a fragmented sector. Last week J-Star exited Apo Plus Station (APS) after a two-year holding...
Exits | 25 Oct 2012 |
International Finance Corporation (IFC), the investment arm of the World Bank, is expected to anchor Shanghai Fosun Pharmaceutical’s Hong Kong IPO alongside Prudential Financial. The total cornerstone commitment is $75 million out of a targeted $600...
Healthcare | 17 Oct 2012 |
Mid-market Japanese GP J-Star has sold its majority stake in the pharma-focused contract sales company Apo Plus Station (APS) to Qol, a Tokyo-based pharmaceutical firm.
North Asia | 16 Oct 2012 |
Hong Kong-based Themes Investment Partners has led a $20 million equity financing round in LoneStar Heart, a California-based biomedical company developing new therapies for patients with heart failure.
Greater China | 11 Oct 2012 |
For Asiri Hospital Holdings (AHH) in Sri Lanka, read India’s Sterling Hospitals in India. Actis, which has acquired a $32 million equity stake in the Sri Lankan healthcare operator, found itself looking at a similar market dynamic when it first invested...
Expansion | 10 Oct 2012 |
Emerging markets-focused private equity firm Actis has invested $32 million for approximately 30% of Asiri Hospital Holdings (AHH), Sri Lanka’s largest private hospital group. The company operates three facilities in Colombo and two in Matara, with...
South Asia | 04 Oct 2012 |
Norwest Venture Partners (NVP) has bought a 10% stake in India’s Thyrocare Technologies from the medical diagnostics services provider’s promoters for INR1.2 billion ($22 million).
Healthcare | 27 Sep 2012 |
Wellington Partners Venture Capital has led a EUR2.6 million ($3.4 million) Series A round of financing in AyoxxA Biosystems, a biotech firm based in Singapore and Germany. The capital will provide AyoxxA with the resources to scale-up production of bead-based...
Southeast Asia | 24 Sep 2012 |
Vyome Biosciences, a Delhi-based biopharmaceutical company that focuses on dermatology, has raised $3.3 million in Series A financing. The round was led by IndoUS Venture Partners, with Aarin Capital and existing investor Navam Capital also participating....
South Asia | 13 Sep 2012 |
Max India, which is backed by Goldman Sachs, International Financial Corporation (IFC) and Temasek Holdings, has sold its biaxially oriented polypropylene (BOPP) film division to Germany's Treofan for INR5.4 billion ($97 million). The divestment allows...
South Asia | 13 Sep 2012 |
CITIC Private Equity is supporting a $331 million management buyout offer for NASDAQ-listed Chinese pharmaceuticals company 3SBio. It is the latest in a string of attempted take-private deals for US-traded Chinese firms that for a variety of reasons are...
Buyouts | 13 Sep 2012 |
RRJ Capital is said to have injected $50 million in Chinese biotech company Triplex Biosciences, taking an 11-19% stake in the company.
Healthcare | 07 Sep 2012 |
Norwest Venture Partners (NVP) has invested INR250 million ($4.5 million) in NationWide Primary Healthcare Services, an Indian retail chain of primary care clinics.
Healthcare | 06 Sep 2012 |
Olympus-backed DM Healthcare, a Dubai-based healthcare services provider which gets a majority of its business in the Middle East, will invest INR15 billion ($270 million) in India. The company hopes this will help boost overall revenues by 40% to INR23...
South Asia | 04 Sep 2012 |
Updating your subscription status
AVCJ Europe will bring the region's most successful and powerful fund managers to London. Attendees will hear thought-provoking dialogue about investment opportunities and challenges across Asia, and will learn how leading funds have achieved success in the world's most resilient growth engine. Register now, for the opportunity to network with Asian-based firms and some of Europe's largest institutional investors who are looking to expand their portfolios and contacts in Asia.
Date: 13 June 2013
Venue: Commonwealth Club, London
The 14th Annual AVCJ Japan Private Equity & Venture Forum, taking place on 27-28 June 2013 at the Conrad Hotel in Tokyo, will feature can't miss analysis of Japan's private equity industry including an in-depth look at how the sector can benefit from the rapidly improving economy. After years of low-growth, has a new era finally dawned? Register now to hear from more than 45 of the most experienced and well-respected players in Japan, as well as some of the biggest domestic and international institutional investors.
Date: 27-28 June 2013
Venue: Conrad, Tokyo